SNT 3.13% 3.3¢ syntara limited

Ann: Appendix 3B - Grant of Employee Peformance Rights, page-7

  1. 1,181 Posts.
    lightbulb Created with Sketch. 12
    You are trooper!

    I think it bodes well that if LOXL2 is successful in trials, Pharmaxis should be able to negotiate a decent upfront based on having 2 approved products and 2 Phase II trials with BI.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
0.001(3.13%)
Mkt cap ! $42.58M
Open High Low Value Volume
3.1¢ 3.4¢ 3.1¢ $77.05K 2.374M

Buyers (Bids)

No. Vol. Price($)
2 351201 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 673566 1
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.